6
adducts.8-10 However, the structures of the adducts are
not established with certainty due to insufficiency of the
amounts available and the failure of attempts to develop
satisfactory methods for their synthesis.1
N -Arylation of 2′-Deoxyadenosine via
Copper-Catalyzed Direct Coupling with
Aryl Halides
1,12
Chongzhao Ran, Qing Dai, and Ronald G. Harvey*
In connection with studies aimed at devising practical
methods for synthesis of these adducts, we investigated
copper-catalyzed coupling of aryl halides with dA as a
Ben May Institute for Cancer Research, University of
Chicago, Chicago, Illinois 60637
6
13
synthetic route to N -PAH-dA adducts (Scheme 1).
Received November 18, 2004
6
Synthesis of N -aryl-dA adducts by Buchwald-Hartwig
Pd-catalyzed coupling of a suitably protected derivative
of dA with an o-nitroaryl bromide has been reported.
1
4a
However, the method is limited to aryl halides with
strong electron-withdrawing groups, and attempted analo-
gous coupling of aryl halides with electron-donating
groups was not successful.1 The classic copper-catalyzed
4b
1
5
Ulmann reaction of aryl halides with arylamines was
impractical because of the relatively severe conditions
required. However, it has been shown more recently that
copper-mediated coupling can take place under milder
6
A general method for efficient N -arylation of 2′-deoxyad-
15,16
conditions in the presence of various ligands.
Al-
enosine via copper-catalyzed direct coupling with aryl iodides
and bromides is described. The method is useful for aryl
halides with either electron-donating or electron-withdraw-
ing groups.
though palladium-catalyzed coupling of arylamines is
known to proceed under mild conditions,17 the choice of
copper was dictated by its lower cost, relative insensitiv-
ity to air and moisture, anticipated broader substrate
specificity, and the likelihood that protection-deprotec-
tion of the hydroxyl groups of the 2′-deoxyribose compo-
nent would be unnecessary.
Preliminary experiments were conducted to assess the
effectiveness of various ligands for the CuI-catalyzed
reaction of 4-iodotoluene with dA (Table 1). Among the
ligands most frequently employed for copper-mediated
Polycyclic aromatic hydrocarbons (PAHs) and nitro-
samines are strongly implicated as the principal cancer-
causative agents in tobacco smoke,1 and smoking of
cigarettes has been related directly to 30% of all can-
cers. PAH carcinogens formed by combustion of organic
matter, e.g., fossil fuels, are also widespread contami-
nants of urban environments.4,5
PAHs are activated by CYP enzymes to form diol
epoxide metabolites that react with the amino groups of
′-deoxyadenosine (dA) and 2′-deoxyguanosine (dG) in
2,3
(
8) Smithgall, T. E.; Harvey, R. G.; Penning, T. M. J. Biol. Chem.
1
986, 261, 6184-6191; Cancer Res. 1988, 48, 1227-1232; J. Biol.
Chem. 1988, 263, 1814-1820.
2
(9) Penning, T. M.; Onishi, S. T.; Onishi, T.; Harvey, R. G.; Chem.
Res. Toxicol. 1996, 9, 84-92. Flowers, L.; Onishi, S. T.; Penning, T.
M. Biochemistry 1997, 36, 8640. Shou, M.; Harvey, R. G.; Penning, T.
M. Carcinogenesis 1993, 14, 475-482.
DNA to form adducts that lead to mutations and tumor
4
,6,7
induction.
More recent studies have shown that the
PAH dihydrodiol precursors of the diol epoxide metabo-
lites are oxidized by aldo-keto reductase enzymes to
catechols that enter into redox cycles with O to generate
2
quinones and reactive oxygen species. The PAH quino-
nes react with DNA to form stable and depurinating
(10) A third mechanistic pathway that involves activation of PAHs
by CYP peroxidase to generate PAH radical-cations that combine with
DNA to form unstable adducts lost by depurination has also been
proposed: Cavalieri, E. L.; Rogan, E. Xenobiotica 1995, 25, 677. The
relevance of this mechanism is disputed: Melendez-Colon, V.; Luch,
A.; Seidel, A.; Baird, W. Carcinogenesis 1999, 20, 1885.
8
(11) Gopishetty, S. R.; Harvey, R. G.; Lee, S.-H.; Blair, I. A.; Penning,
T. M. In Aldo-Keto Reductases and Toxicant Metabolism; Penning, T.
M., Petrash, J. M., Eds.; ACS Symposium Series No. 865: American
Chemical Society: Washington, DC, 2003; Chapter 9, pp 127-137.
(12) McCoull, K. D.; Rindgen, D.; Blair, I. A.; Penning, T. M. Chem.
Res. Toxicol. 1999, 12, 237-246.
(13) The synthetic route to the PAH quinone adducts of 2′-deoxyri-
bonucleosides entails coupling of protected halogen-substituted deriva-
tives of the PAH quinones (or the corresponding catechols) with dA or
dG, or their derivatives, followed by deprotection (and in the case of
the catechols reoxidation back to quinones).
(14) (a) De Riccardis, F.; Bonala, R. R.; Johnson, F. J. Am. Chem.
Soc. 1999, 121, 10453-10460. (b) Lakshman, M. K.; Keeler, J. C.;
Hilmer, J. H.; Martin, J. Q. J. Am. Chem. Soc. 1999, 121, 6090-6091.
(15) Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.; Lemaire, M.
Chem. Rev. 2002, 102, 1359-1470.
(16) (a) Ley, S. V.; Thomas, A. W. Angew. Chem., Int. Ed. Engl. 2003,
42, 5400-5449. (b) Gujadhur, R.; Venkataraman, D.; Kintigh, J. T.
Tetrahedron Lett. 2001, 42, 4791-4793. (c) Kelkar, A. A.; Patil, N. M.;
Chaudhari, Tetrahedron Lett. 2002, 42, 7143-7146. (d) Ma, D.; Cai,
Q.; Zhang, H. Org. Lett. 2002, 5, 2453-2455. (e) Klapars, A.; Huang,
X.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 7421-7428.
(17) Yang, B. H.; Buchwald, S. L. J. Organomet. Chem. 1999, 576,
125-146. Wolfe, J. P.; Wagaw, S.; Marcoux, J.-F.; Buchwald, S. L. Acc.
Chem. Res. 1998, 31, 805-818. Hartwig, J. F. Angew. Chem., Int. Ed.
1998, 37, 2046-2067.
*
To whom correspondence should be addressed. Fax: (773) 702-
260.
1) Review: Pfiefer, G. P.; Denissenko, M. F.; Olivier, M.; Tretya-
kova, N.; Hecht, S.; Hainaut, P. Oncogene 2002, 21, 7435-7451.
6
(
(
2) International Agency for Research on Cancer. Monographs on
the Evaluation of the Carcinogenic Risks to Humans. Tobacco Smoke
and Involuntary Smoking; IARC: Lyon, France, 2004; Vol. 83.
(3) World Health Organization. Tobacco or Health: A Global Status
Report; WHO: Geneva, 1997; pp 10-48.
4) Harvey, R. G. Polycyclic Aromatic Hydrocarbons: Chemistry and
Carcinogenicity; Cambridge University Press: Cambridge, U.K., 1991.
5) International Agency for Research on Cancer. Monographs on
(
(
the Evaluation of the Carcinogenic Risk of Chemicals to Humans.
Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental
and Experimental Data; IARC: Lyon, France, 1983; Vol. 32.
(
6) Jeffrey, A. M.; Weinstein, I. B.; Jennette, K.; Grzeskowiak, K.;
Nakanishi, K.; Harvey, R. G.; Autrup, H.; Harris, C. Nature (London)
977, 269, 348-350. Jennette, K.; Jeffrey, A. M.; Blobstein, S. H.;
Beland, F. A.; Harvey, R. G.; Weinstein, I. B. Biochemistry 1977, 16,
32-938.
7) Dipple, A. In DNA Adducts: Identification and Biological
1
9
(
Significance; Hemminki, K., Dipple, A., Segerb a¨ ck, D., Kadulbar, F.
F., Shuker, D., Bartsch, H., Eds.; IARC Scientific Publication No. 125;
IARC: Lyon, France, 1994; pp 107-129.
10.1021/jo040284w CCC: $30.25 © 2005 American Chemical Society
3724
J. Org. Chem. 2005, 70, 3724-3726
Published on Web 03/30/2005